{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T01:03:02Z","timestamp":1648947782060},"reference-count":31,"publisher":"American Society of Consultant Pharmacists","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Consultant Pharmacist"],"published-print":{"date-parts":[[2013,3,1]]},"DOI":"10.4140\/tcp.n.2013.160","type":"journal-article","created":{"date-parts":[[2013,3,6]],"date-time":"2013-03-06T03:03:30Z","timestamp":1362539010000},"page":"160-166","source":"Crossref","is-referenced-by-count":2,"title":["Drug-Induced Rash: Nuisance or Threat?"],"prefix":"10.4140","volume":"28","author":[{"given":"Jeannette Y.","family":"Wick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2625","published-online":{"date-parts":[[2013,3,5]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1124\/pr.56.2.4","article-title":"Aging biology and geriatric clinical pharmacology","volume":"56","author":"AJ McLean","year":"2004","journal-title":"Pharmacol Rev"},{"key":"2","volume-title":"Harrison's Principles of Internal Medicine","author":"K Shinkai","year":"2008"},{"key":"3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2165\/00002512-200522050-00003","article-title":"Predicting and preventing adverse drug reactions in the very old","volume":"22","author":"L Merle","year":"2005","journal-title":"Drugs Aging"},{"key":"4","first-page":"1386","volume-title":"Fitzpatrick's Dermatology in General Medicine","author":"IM Freedberg","year":"2003"},{"key":"5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.iac.2004.03.007","article-title":"Dermatologic drug reactions","volume":"24","author":"JK McKenna","year":"2004","journal-title":"Immunol Allergy Clin North Am"},{"key":"6","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2165\/00002018-200730110-00003","article-title":"Drug-induced skin, nail and hair disorders","volume":"30","author":"L Valeyrie-Allanore","year":"2007","journal-title":"Drug Saf"},{"key":"7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000335617","article-title":"Uncomplicated drug-induced disseminated exanthemas","volume":"97","author":"AJ Bircher","year":"2012","journal-title":"Chem Immunol Allergy"},{"key":"8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.tox.2004.12.023","article-title":"Drug-induced exanthems","volume":"209","author":"N Yawalkar","year":"2005","journal-title":"Toxicology"},{"key":"9","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/j.1398-9995.2007.01518.x","article-title":"Amoxicillin-induced exanthema in patients with infectious mononucleosis: allergy or transient immunostimulation?","volume":"62","author":"U Jappe","year":"2007","journal-title":"Allergy"},{"key":"10","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1345\/aph.1G140","article-title":"Amoxicillin\/telithromycin-induced rash in infectious mononucleosis","volume":"39","author":"KA Wargo","year":"2005","journal-title":"Ann Pharmacother"},{"key":"11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2133\/dmpk.DMPK-11-RV-116","article-title":"A recent update of pharmacogenomics in drug-induced severe skin reactions","volume":"27","author":"CY Wei","year":"2012","journal-title":"Drug Metab Pharmacokinet"},{"key":"12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1056\/NEJMicm1013871","article-title":"Images in clinical medicine. Fixed drug eruption","volume":"365","author":"IC Duarte de Sousa","year":"2011","journal-title":"N Engl J Med"},{"key":"13","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1365-4632.2006.02853.x","article-title":"Fixed drug eruption (FDE): changing scenario of incriminating drugs","volume":"45","author":"VN Sehgal","year":"2006","journal-title":"Int J Dermatol"},{"key":"14","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0190-9622(89)70325-X","article-title":"Steroid acne","volume":"21","author":"RM Hurwitz","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"15","first-page":"399","article-title":"Drug eruptions in children","volume":"14","author":"S Knowles","year":"1999","journal-title":"Adv Dermatol"},{"key":"16","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1200\/JCO.2008.16.2933","article-title":"Sweet syndrome associated with granulocyte colony-stimulating factor","volume":"26","author":"S Bidyasar","year":"2008","journal-title":"J Clin Oncol"},{"key":"17","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1345\/aph.1H563","article-title":"Drug-induced Sweet's syndrome","volume":"41","author":"DF Thompson","year":"2007","journal-title":"Ann Pharmacother"},{"issue":"2","key":"18","first-page":"1","article-title":"Sweet's syndrome\u2014a comprehensive review of an acute febrile neutrophilic dermatosis","volume":"26","author":"PR Cohen","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"19","first-page":"351210","article-title":"Dermatologic toxicities from monoclonal antibodies and tyrosine kinase inhibitors against EGFR pathophysiology and management","author":"SE Abdullah","year":"2012","journal-title":"Chemother Res Pract"},{"key":"20","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00520-011-1197-6","article-title":"MASCC Skin Toxicity Study Group. Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities","volume":"19","author":"ME Lacouture","year":"2011","journal-title":"Support Care Cancer"},{"key":"21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1188\/08.ONF.103-111","article-title":"Clinical approaches to minimize rash associated with EGFR inhibitors","volume":"35","author":"K Oishi","year":"2008","journal-title":"Oncol Nurs Forum"},{"key":"22","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"JC Roujeau","year":"1994","journal-title":"N Engl J Med"},{"key":"23","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","article-title":"The DRESS syndrome: a literature review","volume":"124","author":"P Cacoub","year":"2011l","journal-title":"Am J Med"},{"key":"24","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1517\/14740338.2012.705828","article-title":"Anticonvulsant hypersensitivity syndrome: an update","volume":"11","author":"SR Knowles","year":"2012","journal-title":"Exp Opin Drug Saf"},{"key":"25","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jaci.2004.06.043","article-title":"Canadian 2003 international consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema","volume":"114","author":"T Bowen","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"26","article-title":"Inflammation and coagulation in urticaria and angioedema","author":"M Cugno","year":"2012","journal-title":"Curr Vasc Pharmacol"},{"key":"27","first-page":"1","article-title":"Incidence of adverse events with telmisartan compared with ACE inhibitors: evidence from a pooled analysis of clinical trials","volume":"6","author":"G Mancia","year":"2012","journal-title":"Patient Prefer Adherence"},{"key":"28","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2500\/aap.2011.32.3469","article-title":"Update on angioedema: evaluation, diagnosis, and treatment","volume":"32","author":"JA Bernstein","year":"2011","journal-title":"Allergy Asthma Proc"},{"key":"29","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1586\/eci.11.66","article-title":"The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"7","author":"M Mockenhaupt","year":"2011","journal-title":"Exp Rev Clin Immunol"},{"key":"30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.crohns.2011.03.014","article-title":"Stevens-Johnson syndrome with sulfasalazine treatment: report of two cases","volume":"5","author":"L Tremblay","year":"2011","journal-title":"J Crohns Colitis"},{"key":"31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4103\/0022-3859.81865","article-title":"Drug-induced Stevens- Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study","volume":"57","author":"M Barvaliya","year":"2011","journal-title":"J Postgrad Med"}],"container-title":["The Consultant Pharmacist"],"original-title":[],"deposited":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T08:49:59Z","timestamp":1498034999000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ingentaconnect.com\/content\/ascp\/tcp\/2013\/00000028\/00000003\/art00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,1]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3,1]]}},"alternative-id":["6602053TM2803111"],"URL":"https:\/\/doi.org\/10.4140\/tcp.n.2013.160","relation":{},"ISSN":["0888-5109"],"issn-type":[{"value":"0888-5109","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3,1]]}}}